Cargando…
The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?
Interstitial fibrosis is the common endpoint of end-stage chronic kidney disease (CKD) leading to kidney failure. The clinical course of many renal diseases, and thereby of CKD, is highly variable. One of the major challenges in deciding which treatment approach is best suited for a patient but also...
Autores principales: | Genovese, Federica, Manresa, Alba A, Leeming, Diana Julie, Karsdal, Morten Asser, Boor, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986639/ https://www.ncbi.nlm.nih.gov/pubmed/24678881 http://dx.doi.org/10.1186/1755-1536-7-4 |
Ejemplares similares
-
Precision-Cut Kidney Slices as a Tool to Understand the Dynamics of Extracellular Matrix Remodeling in Renal Fibrosis
por: Genovese, Federica, et al.
Publicado: (2016) -
Biglycan fragmentation in pathologies associated with extracellular matrix remodeling by matrix metalloproteinases
por: Genovese, Federica, et al.
Publicado: (2013) -
Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD
por: Bihlet, Asger Reinstrup, et al.
Publicado: (2017) -
Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023) -
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model
por: Veidal, Sanne Skovgård, et al.
Publicado: (2012)